NSE · BANKA
Banka Bioloo Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹16 Cr with net profit ₹0 Cr — a 2.26% net margin, versus 0.6% the period before.
Shareholding
As of 2026-09-30
- Promoter52.02%
- Public47.98%
4,752 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.36× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Miscellaneous · ranked #249 of 552 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| National Stock Exchange Of India Ltd. | ₹4,72,317 Cr | 42.76 | 11.29 | 26.24% | 62.66% |
| Adani Ports & Special Economic Zone Ltd. | ₹4,46,185 Cr | 32.27 | 4.36 | 13.33% | 31.98% |
| Eternal Limited | ₹3,50,452 Cr | 712.06 | 11.19 | 1.58% | 0.63% |
| BSE Limited | ₹1,54,996 Cr | 50.28 | 19.49 | 38.76% | 53.09% |
| Vedanta Aluminium Metal Limited | ₹1,47,050 Cr | 7.78 | 6.37 | 80.07% | 23.43% |
| GAIL (India) Ltd. | ₹1,22,159 Cr | 9.68 | 1.26 | 13.05% | 7.91% |
| One 97 Communications Ltd. | ₹1,15,268 Cr | 137.5 | 6.93 | 5.15% | 8.95% |
| Meesho Limited | ₹1,08,125 Cr | — | 25.7 | -21.93% | -6.19% |
| GMR Airports Limited | ₹1,05,277 Cr | 164.58 | 0 | -25.64% | 3.13% |
| Multi Commodity Exchange of India Ltd. | ₹89,961 Cr | 50.01 | 25.6 | 51.22% | 58.86% |
| Banka Bioloo Limited(this company) | ₹89 Cr | 142.81 | 2.25 | 1.63% | 0.6% |
AI analysis
AI-generated · google/gemini-2.5-flashBanka Bioloo Limited is listed with a market capitalization of Rs 98 Cr. The company reported revenue of Rs 54.5 Cr with an 8.4% revenue growth. Its profit margin stands at 63.1%, and its EPS is Rs 0.59. The company's 52-week high was Rs 97.88 and its 52-week low was Rs 41.
Positives
- +The profit margin for the company is high at 63.1%.
- +Return on Equity (ROE) is significantly high at 163.4%.
- +The company's promoter holding is 52.07%, indicating a majority stake held by promoters.
- +No promoter shares are pledged, with a value of 0%.
Negatives
- −The company's PE ratio is 61.55, which may indicate a high valuation.
- −Return on Capital Employed (ROCE) is relatively low at 4.63%.
- −The company is under ESM 1 surveillance.
- −Quarterly net profit for December 2025 was negative at Rs -0.15 Cr.
Financial Performance
The company's annual revenue for March 2026 was Rs 18.02 Cr, following a revenue of Rs 15.93 Cr in December 2025. Quarterly net profit for March 2026 was Rs 1.58 Cr, a significant increase from a net loss of Rs 0.15 Cr in December 2025. The company's overall revenue growth was 8.4%.
Profitability & Returns
Banka Bioloo Limited achieved a profit margin of 63.1%. The Return on Equity (ROE) was 163.4%, and the Return on Capital Employed (ROCE) stood at 4.63%. The company's earnings per share (EPS) was Rs 0.59.
Balance Sheet
The company has a book value of Rs 36.19. The debt-to-equity ratio is 0.85, indicating its leverage. No dividend yield was reported.
Ownership & Pledges
As of March 31, 2026, promoters held 52.07% of the shares, while the public held 47.93%. There was no promoter pledging reported. The number of shareholders as of March 31, 2026, was 5420.
Regulatory & Surveillance
The company is currently under ESM (Enhanced Surveillance Measure) Stage 1, which indicates increased monitoring by regulatory bodies. This includes specific measures for surveillance.
Data as of — price: 2026-11-07 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.